News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,789 Results
Type
Article (1921)
Company Profile (2)
Press Release (71866)
Section
Business (25347)
Career Advice (9)
Deals (4554)
Drug Development (8161)
FDA (1804)
Job Trends (799)
News (37039)
Policy (3562)
Tag
2027 BioCapital Standard (1)
Academia (98)
Accelerated approval (5)
ADA (2)
Allergies (23)
Alliances (8174)
ALS (18)
Alzheimer's disease (191)
Antibody-drug conjugate (ADC) (125)
Approvals (1979)
Artificial intelligence (40)
ASCO (37)
Autoimmune disease (38)
Automation (2)
Bankruptcy (9)
Best Places to Work (584)
BIO (9)
Biologics (1)
Biosimilars (98)
BioSpace Insights (1)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (64)
Cancer (677)
Cardiovascular disease (26)
Career advice (9)
CAR-T (17)
CDC (1)
CDMO (4)
Celiac Disease (1)
Cell therapy (63)
Cervical cancer (5)
Clinical research (7751)
Collaboration (353)
Commercialization (3)
Compensation (28)
Complete response letters (7)
COVID-19 (200)
CRISPR (1)
C-suite (107)
Cystic fibrosis (8)
Data (893)
Depression (18)
Dermatology (11)
Diabetes (45)
Diagnostics (652)
Digital health (7)
Drug discovery (47)
Drug pricing (1)
Duchenne muscular dystrophy (47)
Earnings (8260)
Events (7645)
Executive appointments (79)
FDA (2352)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (166)
Gene editing (7)
Generative AI (2)
Gene therapy (41)
GLP-1 (82)
Government (243)
Grass and pollen (1)
Guidances (40)
Healthcare (1097)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (27)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (30)
Infectious disease (228)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (43)
IPO (1641)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Layoffs (6)
Legal (953)
Licensing (9)
Liver cancer (22)
Longevity (3)
Lung cancer (126)
Lymphoma (57)
Machine learning (1)
Manufacturing (142)
Marketing (4)
MASH (19)
Medical device (1174)
Medtech (1195)
Mergers & acquisitions (3124)
Metabolic disorders (116)
mRNA (8)
Multiple sclerosis (27)
NASH (1)
Neurodegenerative disease (38)
Neuropsychiatric disorders (7)
Neuroscience (359)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (40)
Opinion (2)
Ovarian cancer (35)
Pain (20)
Pancreatic cancer (33)
Parkinson's disease (50)
Partnered (4)
Patents (78)
Patient recruitment (90)
Peanut (1)
People (5213)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2093)
Phase 2 (3282)
Phase 3 (2924)
Pipeline (1391)
Policy (1)
Postmarket research (241)
Preclinical (712)
Press Release (2)
Prostate cancer (28)
Radiopharmaceuticals (29)
Rare diseases (93)
Real estate (607)
Regulatory (3098)
Reports (8)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (22)
Series A (34)
Series B (25)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (424)
Stomach cancer (2)
Supply chain (14)
Vaccines (48)
Venture capital (7)
Weight loss (17)
Women's health (7)
Date
Today (3)
Last 7 days (52)
Last 30 days (216)
Last 365 days (2823)
2026 (2006)
2025 (2685)
2024 (3252)
2023 (3814)
2022 (7002)
2021 (6371)
2020 (5870)
2019 (3861)
2018 (3013)
2017 (3560)
2016 (3176)
2015 (4029)
2014 (3020)
2013 (2604)
2012 (2776)
2011 (2903)
2010 (2663)
Location
Africa (88)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22362)
Australia (2508)
California (862)
Canada (494)
China (547)
Colorado (5)
Connecticut (27)
Delaware (9)
Europe (13543)
Florida (94)
Georgia (18)
Hawaii (1)
Illinois (46)
India (61)
Indiana (28)
Japan (362)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (137)
Massachusetts (684)
Michigan (9)
Minnesota (39)
Missouri (3)
Nebraska (3)
Nevada (11)
New Hampshire (1)
New Jersey (526)
New York (300)
North Carolina (130)
Northern California (373)
Ohio (7)
Oregon (1)
Pennsylvania (160)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (422)
Tennessee (5)
Texas (62)
United States (3292)
Utah (31)
Vermont (1)
Virginia (67)
Washington D.C. (3)
Washington State (63)
Wisconsin (8)
Wyoming (1)
73,789 Results for "evogene ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
Business
Evogene Schedules First Quarter 2024 Financial Results Release
Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development, announced that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024.
May 9, 2024
·
2 min read
Business
Evogene Reports First Quarter 2024 Financial Results
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter period ended March 31, 2024.
May 23, 2024
·
18 min read
Business
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Evogene Ltd. today announced its financial results for the fourth quarter and full-year period ending December 31, 2023.
March 7, 2024
·
19 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - September 7, 2026
September 7, 2026
·
3 min read
Business
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Evogene Ltd announced today that it will release its financial results for the third quarter of 2023 on Thursday, March 7th, 2024.
February 26, 2024
·
2 min read
Business
Evogene Reports Third Quarter 2023 Financial Results
Evogene Ltd today announced its financial results for the third quarter period ended September 30, 2023.
November 15, 2023
·
18 min read
Press Releases
InterCure Ltd. Announces 1-for-5 Reverse Share Split
August 19, 2026
·
5 min read
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
1 of 7,379
Next
